Die folgenden Begriffe wurden einbezogen:
Zentralnervensystem, ZNS, "central nervous system", CNS, 中枢神経系
-
2024,
Yu A, Zeng J, Yu J, Cao S, Li A
CNS Neurosci Ther 30 (3): e14563
-
2024,
Chen Y, Li Z, Yan C, Zou L
CNS Neurosci Ther 30 (3): e14645
-
2024,
Gao M, Peng H, Hou Y, Wang X, Li J, Qi H, Kuang F, Zhang J
Bioelectromagnetics 45 (3): 130-138
-
2024,
Liu J, Guo H, Yang J, Xiao Y, Cai A, Zhao T, Womer FY, Zhao P, Zheng J, Zhang X, Wang J, Zhu R, Wang F
CNS Neurosci Ther 30 (3): e14427
-
2023,
Kar SK, Agrawal A, Silva-Dos-Santos A, Gupta Y, Deng ZD
CNS Spectr: 1-26 [im Druck]
-
2023,
Liu L, Hu H, Wu J, Koleske AJ, Chen H, Wang N, Yu K, Wu Y, Xiao X, Zhang Q
CNS Neurosci Ther [im Druck]
-
2023,
Ruwaili A, Fatima R, Hussain A, Uzair M, Abualait T, Imdad K, Bashir S
CNS Neurol Disord Drug Targets [im Druck]
-
2023,
Patel S, Silvi S, Desai S, Rahman F, Depa N, Hanif S, Rizvi S, Hsieh YC, Malik P, Patel U, Mansuri Z, Mercy RP, Aedma K, Parikh T
Prim Care Companion CNS Disord 25 (5): 22r03423
-
2023,
Cooper I, Last D, Ravid O, Rand D, Matsree E, Omesi L, Shemesh C, Liberman M, Zach L, Furman O, Daniels D, Liraz-Zaltsman S, Mardor Y, Sharabi S
Fluids Barriers CNS 20: 67
-
2023,
Iszak K, Gronemann SM, Meyer S, Hunold A, Zschüntzsch J, Bähr M, Paulus W, Antal A
Biomedicines 11 (7): 1813
-
2023,
Barkhoudarian G, Badruddoja M, Blondin N, Chowdhary S, Cobbs C, Duic JP, Flores JP, Fonkem E, McClay E, Nabors LB, Salacz M, Taylor L, Vaillant B, Gill J, Kesari S
CNS Oncol 12 (3): CNS102
-
2023,
Zhou CH, Chen YH, Xue SS, Shi QQ, Guo L, Yu H, Xue F, Cai M, Wang HN, Peng ZW
CNS Neurosci Ther 29 (11): 3549-3566
-
2023,
Wei N, Liu H, Ye W, Xu S, Lu C, Dai A, Hou T, Zeng X, Wu J, Chen J
CNS Neurosci Ther 29 (10): 2912-2924
-
2023,
Chen M, Chen Z, Xiao X, Zhou L, Fu R, Jiang X, Pang M, Xia J
IBRO Neurosci Rep 14: 185-194
-
2023,
Kim K, Nan G, Kim L, Kwon M, Lee KH, Cha M, Lee BH
CNS Neurosci Ther 29 (6): 1636-1648
-
2023,
Camacho-Conde JA, Del Rosario Gonzalez-Bermudez M, Carretero-Rey M, Khan ZU
CNS Neurosci Ther 29 (1): 8-23
-
2023,
Akhtar F, Patel PK, Heyat MBB, Yousaf S, Baig AA, Mohona RA, Mutoffar MM, Bhattacharya T, Teelhawod BN, Li JP, Kamal MA, Wu K
CNS Neurol Disord Drug Targets 22 (7): 1070-1089
-
2022,
Koseki T, Kudo D, Yoshida K, Nito M, Takano K, Jin M, Tanabe S, Sato T, Katoh H, Yamaguchi T
Front Neurosci 16: 1034451
-
2022,
Soltani E, Bateni H, Shad MU
Prim Care Companion CNS Disord 24 (4): 21r03144
-
2022,
Ma Y, Yang C, Liang Q, He Z, Weng W, Lei J, Skudder-Hill L, Jiang J, Feng J
Mol Neurobiol 59 (6): 3665-3677
-
2022,
Camacho-Conde JA, Gonzalez-Bermudez MDR, Carretero-Rey M, Khan ZU
CNS Neurosci Ther 28 (1): 5-18
-
2022,
Caballero-Villarraso J, Medina FJ, Escribano BM, Agüera E, Santamaría A, Pascual-Leone A, Túnez I
CNS Neurol Disord Drug Targets 21 (7): 557 - 573
-
2021,
Wu H, Yang L, Liu H, Zhou D, Chen D, Zheng X, Yang H, Li C, Chang J, Wu A, Wang Z, Ren N, Lv S, Liu Y, Jia M, Lu J, Liu H, Sun G, Liu Z, Liu J, Chen L
CNS Neurosci Ther 27 (12): 1587-1604
-
2021,
Bertagna F, Lewis R, Silva SRP, McFadden J, Jeevaratnam K
Ann N Y Acad Sci 1499 (1): 82-103
-
CNS Spectr: 1-2